Loading patent…
AssigneeDermBiont, Inc.
InventorsRobert Brucker, Yanjun Huang, Nikola Jovanovic, Bhanu Prakash Chowdary Sakhamuri, Ida Lister, Xuecheng Zhang, Sanjay Jain, Emma Jean Mildred Taylor
Estimating the term…
Among other things, disclosed herein are compositions and methods for using human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum. Compositions may improve skin health. Methods may include applying human-isolated or synthetic Alcaligenes faecalis, Bacillus altitudinis, Bacillus pumilus, Bacillus subtilis, or Janthinobacterium lividum over a host or host area, such as skin or mucosa to minimize the presence of one or more pathogenic microbes, maximize therapeutic effects of one or more additional therapeutics, and/or improve health of a host or host area.
A composition comprising a probiotic, wherein the probiotic comprises human-isolated or synthetic Alcaligenes faecalis in an amount effective to treat a disease, disorder, or condition associated with a pathogenic microorganism, and a cryoprotectant, wherein the probiotic comprises a nucleic acid sequence at least 95% identical to that of SEQ ID NO:
A probiotic composition comprising Alcaligenes faecalis and at least one cryoprotectant for use as a medicament, wherein the probiotic comprises a nucleic acid sequence at least 95% identical to that of SEQ ID NO:
Dependencies are inferred from the claim text.